Abbott Laboratories Limited

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
Telephone: +44 (0)1628 773 355
Fax: +44 (0)1628 644 185
WWW: http://www.abbottuk.com
Medical Information e-mail: ukmedinfo@abbott.com
Out of Hours Telephone: +44 (0)1628 774 920
Patient Information Leaflet last updated on the eMC: 24/09/2009
PIL Norvir Soft Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/09/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to how the medicine works
Updated on 05/08/2008 and displayed until 24/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
  • Change due to user-testing of patient information
  • Change to name of manufacturer
Updated on 05/12/2007 and displayed until 05/08/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 22/08/2007 and displayed until 05/12/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to drug interactions
  • Change to Further Information section
  • Change to date of revision
Updated on 07/03/2007 and displayed until 22/08/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 24/01/2007 and displayed until 07/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 19/01/2007 and displayed until 24/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 15/12/2006 and displayed until 19/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to Further Information section
Updated on 29/09/2006 and displayed until 15/12/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 11/03/2005 and displayed until 29/09/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/02/2002 and displayed until 11/03/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   ritonavir


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk